Develops and manufactures pharmaceutical products for topical therapy of hard-to-heal wounds.
Visit website
Biotechnology Hub
Axis Biotec: biotechnology, evidence-based regenerative medicine and applied cryogenics hub.
Ecosystem with Silvestre Labs, Cryopraxis, CellPraxis and BioNK — science, quality and translation for health.
Educational content. Not a substitute for medical advice. No therapeutic promises.
30+
Years of Experience
4
Specialized Companies
50k+
Preserved Samples
100%
Scientific Commitment
Ecosystem
Ecosystem companies
Four specialized companies, each a leader in its segment, integrated under Axis Biotec.
Cryopreserves stem cells and biological materials following international quality standards.
Visit website
Develops and manufactures ATPs (gene therapy, cell therapy and tissue engineering) per ANVISA regulations.
Visit website
Nossa História
Quem somos: fundadores, cientistas e três décadas de biotecnologia brasileira
O ecossistema Axis Biotec Brasil nasceu da convergência entre farmacotécnica, criobiologia e medicina regenerativa — construído por uma família de cientistas e gestores dedicados à biotecnologia auditável no Brasil.
Luis Eduardo da Cruz
Também conhecido como Eduardo Cruz — CEO e fundador do grupo.
Luis Eduardo da Cruz é o criador da Silvestre Labs e o desenvolvedor dos produtos Dermazine, Colzen e Dermacerium — linha farmacêutica dedicada a cicatrização, reparo tecidual e cuidado dermatológico.
Farmacêutico e empreendedor, lidera hoje a estratégia científica e regulatória do ecossistema Axis Biotec Brasil, com foco em Produtos de Terapia Avançada (PTA) e medicina regenerativa.
Simone Amaral da Silva Cruz, MBA
COO e cofundadora — publicitária, MBA COPPEAD-UFRJ, 30+ anos em gestão de empresas de biotecnologia.
Simone Amaral da Silva Cruz é publicitária, MBA COPPEAD-UFRJ, com 30+ anos de experiência em gestão de empresas do setor de biotecnologia. É mentora da criação da Cryopraxis Criobiologia Ltda e reconhecida como pioneira na gestão de criobiologia no Brasil.
Conduz operações, governança, compliance e estratégia de go-to-market do grupo, articulando a ponte entre ciência, regulação e sustentabilidade financeira das empresas do ecossistema.
Produtos da Silvestre Labs desenvolvidos por Luis Eduardo da Cruz
Dermazine
Solução dermatológica desenvolvida para cicatrização e reparo tecidual.
Criado por Luis Eduardo da Cruz · Silvestre Labs
Colzen
Produto de referência da Silvestre Labs em cuidado da pele e reparo cutâneo.
Criado por Luis Eduardo da Cruz · Silvestre Labs
Dermacerium
Formulação para tratamento de feridas e suporte à cicatrização.
Criado por Luis Eduardo da Cruz · Silvestre Labs
CellPraxis · Direção médico-científica
Na CellPraxis, destacamos o trabalho da Dra. Carolina Cruz, bióloga e médica especialista em medicina regenerativa, responsável pela direção médico-científica da operação. Sua atuação garante rigor translacional entre pesquisa básica, evidência clínica e desenvolvimento de terapias celulares dentro do ecossistema Axis Biotec Brasil.
Knowledge Hub
Articles & Evidence
Evidence-based educational content on biotechnology, regenerative medicine and applied cryogenics.
Nenhum artigo encontrado nesta categoria.
How to use this Hub
Start with a topic — use the editorial filters above.
Read the summary answer at the top of each article to decide if you want to dive deeper.
Access references, FAQ and internal links at the end of each article.
Editorial Transparency
Editorial policy and transparency
All content published in this hub is educational and evidence-based. We clearly separate pre-clinical research, clinical trials and approved use. We make no therapeutic promises. This content does not substitute medical advice; when we discuss business, it does not constitute financial advice.
Read full editorial policyAbout Us
Who is Axis Biotec Brazil
Axis Biotec Brazil is a business group bringing together specialized biotechnology companies: Silvestre Labs, Cryopraxis, CellPraxis and BioNK. Together, they form an ecosystem focused on topical wound therapy, cryopreservation and cell logistics, advanced therapy product development and NK cell research.
With over 30 years of experience, the group operates with a focus on quality, certified infrastructure and scientific rigor. Operations follow international manufacturing and regulatory standards.
Certified Infrastructure
International quality standards
Our Mission
To develop, manufacture and qualify biotechnology solutions — from topical wound therapy to cryopreservation, from advanced therapy products to NK cell research — with scientific rigor, quality and responsibility.
Our Vision
To be a reference in biotechnology in Latin America, with a focus on research, manufacturing quality and responsible clinical translation.
Our Values
Scientific Excellence
Committed to the highest standards of quality and scientific rigor in all our operations.
Collaboration
We work in synergy between our companies and partners to amplify positive health impact.
Continuous Innovation
We constantly invest in research and development to lead the advancement of biotechnology.
Social Responsibility
We believe that science should serve the well-being of all society.
Frequently Asked Questions
FAQ
Find answers to the main questions about our services, technologies and how we can help you.
Transparency
Documents & Standards
Access our institutional documentation, policies and reports to learn more about our operations.
Privacy Policy (LGPD)
How we collect, use and protect your personal data under LGPD.
PDF • 245 KB
Terms of Use
Terms and conditions for using our websites and services.
PDF • 189 KB
Quality Policy
Quality Management System focused on safety and continuous improvement.
PDF • 1.2 MB
Code of Ethics
Principles of integrity, respect and scientific responsibility.
PDF • 312 KB
Annual Report 2025
Highlights: exosomes, NK cells, LipAge project and regulatory achievements.
PDF • 3.5 MB
Certifications & Licenses
Cryopraxis and Silvestre Labs certifications with Anvisa.
PDF • 890 KB
Leadership
The People Behind Axis Biotec
Meet the professionals who lead the operations and strategy of the Axis Biotec ecosystem.
Dr. Luís Eduardo da Cruz
CEO & Founder
Farm Sci, MBA, Innovation Manager with over 30 years of experience in biotechnology.
Simone Amaral da Silva Cruz
COO
Publicitária and MBA COPPEAD-UFRJ, with 30+ years of experience managing biotechnology companies. Executive in governance, strategy and operational structuring for health and biotechnology businesses.
Dr. Guilherme Barbieri
Pharmacotechnical Development Manager
Industrial Pharmacist, MBA, with 25 years of experience in pharmacotechnical development and technology transfer project management.
Dr. José Villa
Operations, Regulatory & Quality Assurance Manager
Industrial Pharmacist, MBA, with 30 years of experience in Operations, Regulatory Affairs, Quality Assurance and Compliance.
Dr. Carolina Cruz
R&D Director
Physician and Biologist, Cell Therapy Researcher focused on Inflammation and Pain.
Dr. Valeria Povolotsky
Strategy & Partnering Advisor
Biotech and Pharma Partnering and Strategy executive, ex-Roche-Genentech, with 25+ years of experience. Board Director at CryoPraxis, BioNKc, and CellPraxis, responsible for Business Development and Partnering. Ph.D. in Clinical Pharmacology, with executive education at Harvard Law School, Wharton Business School, and Academy of Competitive Intelligence.